Valeant Pharma (VRX) Adds to Recent Gains
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Valeant Pharma (NYSE: VRX) adding to recent gains on trader talk management will be meeting with the Morgan Stanley analyst that upgraded the stock last week. Shares are up 4.4%.
Shares of VRX are up nearly 23% since the upgrade from David Risinger on August 17.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Valeant Pharma (VRX) Moves Off Lows on Bill Miller Comments
- BioCryst Pharma (BCRX) Shares Ramp to Session Highs Amid Upcoming Galidesivir Data Presentation
- Valeant Pharma (VRX) Said 'Very Close' on One or More Asset Sales
Create E-mail Alert Related CategoriesTrader Talk
Related EntitiesMorgan Stanley
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!